I33.0

Acute and subacute infective endocarditis

Acute and subacute infective endocarditis (IE) is a serious and potentially life-threatening infection of the endocardium, most commonly involving the heart valves. The condition is characterized by the formation of vegetations—masses composed of bacteria, fungi, platelets, and fibrin—which can lead to progressive valvular destruction, perivalvular abscesses, and systemic embolization. Acute endocarditis typically presents with a rapid, fulminant onset and is often caused by highly virulent organisms such as Staphylococcus aureus, frequently affecting previously normal heart valves. Subacute endocarditis follows a more indolent course, often caused by less virulent organisms like Viridans group streptococci, and typically occurs on valves already damaged by congenital or rheumatic disease. Clinical management requires prolonged courses of targeted intravenous antibiotics and, in many cases, surgical intervention to repair or replace damaged valves and eliminate the source of infection.

Clinical Symptoms

  • Fever (often high in acute, low-grade in subacute)
  • New or changing heart murmur
  • Chills and rigors
  • Night sweats
  • Fatigue and generalized malaise
  • Shortness of breath (dyspnea) especially with exertion
  • Janeway lesions (painless red spots on palms or soles)
  • Osler nodes (painful, tender nodules on pads of fingers or toes)
  • Roth spots (retinal hemorrhages with pale centers)
  • Splinter hemorrhages under the fingernails or toenails
  • Petechiae on skin, conjunctiva, or oral mucosa
  • Splenomegaly
  • Unexplained weight loss
  • Muscle and joint aches
  • Neurological deficits or stroke due to embolic events

Common Causes

  • Staphylococcus aureus (primary cause of acute IE and IVDU-associated IE)
  • Viridans group streptococci (primary cause of subacute IE)
  • Enterococcus species (associated with GI or GU procedures)
  • HACEK group organisms (Haemophilus, Aggregatibacter, Cardiobacterium, Eikenella, Kingella)
  • Fungal pathogens (e.g., Candida, Aspergillus), more common in immunocompromised patients
  • Intravenous drug use (IVDU)
  • Presence of prosthetic heart valves or intracardiac devices
  • Prior history of infective endocarditis
  • Congenital heart disease (e.g., VSD, Tetralogy of Fallot)
  • Acquired valvular dysfunction (e.g., Rheumatic heart disease, Mitral valve prolapse)
  • Chronic indwelling venous catheters
  • Poor oral hygiene or invasive dental procedures

Documentation & Coding Tips

Identify and document the specific causative infectious organism to capture the full clinical picture and ensure appropriate secondary coding.

Example: Patient presents with acute infective endocarditis of the native mitral valve. Blood cultures are positive for Methicillin-resistant Staphylococcus aureus (MRSA). Plan includes starting IV Vancomycin with infectious disease consultation. Billing Focus: Explicitly links the infection (I33.0) with the causative agent (B95.62). Risk Adjustment: MRSA infection increases the HCC weight due to increased resource intensity and severity.

Billing Focus: Requires an additional code from categories B95-B97 to identify the infectious agent.

Specify the exact heart valve or valves involved in the infective process to support medical necessity for surgical interventions.

Example: Transesophageal echocardiogram confirms 1.2 cm mobile vegetation on the aortic valve with associated severe aortic regurgitation. Diagnosed with acute subacute infective endocarditis of the aortic valve. Billing Focus: Clearly identifies the anatomical site to justify cardiac imaging and potential valve replacement. Risk Adjustment: Specific valve involvement helps categorize the severity of the cardiac manifestation.

Billing Focus: Anatomical specificity supports the use of specific echocardiography and cardiothoracic surgical codes.

Distinguish between native valve and prosthetic valve endocarditis as this significantly alters the coding and risk profile.

Example: Patient with a history of mechanical mitral valve replacement (Z95.2) now presents with subacute infective endocarditis of the prosthetic mitral valve. Billing Focus: Distinguishes between I33.0 and T82.7- codes for prosthetic valve infection. Risk Adjustment: Prosthetic valve involvement represents a higher risk tier for surgical revision and long-term complications.

Billing Focus: Correctly differentiates between primary endocarditis and complications of a cardiac device or graft.

Document any embolic manifestations or systemic complications such as septic emboli to the brain, lungs, or spleen.

Example: Acute infective endocarditis complicated by septic emboli to the brain resulting in a small embolic infarct in the right middle cerebral artery territory. Billing Focus: Supports the use of additional codes for cerebrovascular events (I63.411). Risk Adjustment: Systemic embolization drastically increases the HCC risk score by demonstrating multi-organ involvement.

Billing Focus: Requires additional codes for the site of the embolism to reflect the full extent of the systemic disease.

Clarify the acuity by documenting whether the presentation is acute or subacute, as this impacts the expected clinical course and treatment urgency.

Example: Patient presents with a 2-day history of high fever, rigors, and new-onset murmur, consistent with acute infective endocarditis. Billing Focus: Clinical acuity supports the medical necessity for high-level E/M services (99215). Risk Adjustment: Acute presentations often require intensive care and reflect higher immediate resource utilization.

Billing Focus: Supports the selection of higher intensity E/M codes and justifies inpatient status.

Relevant CPT Codes

Related Diagnoses

Hierarchy